ES423959A1 - Oral compositions for plaque caries and calculus retardation with reduced staining tendencies - Google Patents

Oral compositions for plaque caries and calculus retardation with reduced staining tendencies

Info

Publication number
ES423959A1
ES423959A1 ES423959A ES423959A ES423959A1 ES 423959 A1 ES423959 A1 ES 423959A1 ES 423959 A ES423959 A ES 423959A ES 423959 A ES423959 A ES 423959A ES 423959 A1 ES423959 A1 ES 423959A1
Authority
ES
Spain
Prior art keywords
carbon atoms
represent
alkyl
oral compositions
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES423959A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of ES423959A1 publication Critical patent/ES423959A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Abstract

Procedure for obtaining improved oral compositions effective to inhibit the formation of plaques, caries and stones, characterized in that it comprises the steps of: I, reacting (a) from about 0.01 to about 2.5% by weight of a bisbiguanide compound having the generic formula: ** (See formula) ** wherein A and A'each represent either (1) a phenyl radical which may contain as substituents up to two alkyl or alkoxy groups containing from 1 to about 4 carbon atoms, a nitro group or a halogen atom; (2) an alkyl group containing from 1 to about 12 carbon atoms; or (3) alicyclic groups containing from 4 to about 12 carbon atoms; wherein X and X'each represent an alkylene radical containing 1 to 3 carbon atoms; where z and z'can each be 0 or 1; wherein R and R'each represent either hydrogen, an alkyl radical containing from 1 to about 12 carbon atoms, or an aralkyl radical containing from 7 to about 12 carbon atoms; where n is an integer from 2 to 12 inclusive; and wherein the polymethylene (CH2) n chain can be interrupted up to 5 halves of ether, thioether, phenyl or naphthyl; or the pharmaceutically acceptable salts thereof; and (B) a sufficient amount of amine carboxylate compound selected from the group consisting of: nitrilotriacetic acid, acid, its pharmaceutically acceptable water-soluble salts and mixtures thereof, to provide approximately 0.1 to 1.25% by weight of amine carboxylate compound in excess of the amount to be reacted with the bis-biguanide compound; and (II) adjust the pH of the composition to the range between 4 and 9. (Machine-translation by Google Translate, not legally binding)
ES423959A 1973-03-06 1974-03-06 Oral compositions for plaque caries and calculus retardation with reduced staining tendencies Expired ES423959A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33846373A 1973-03-06 1973-03-06

Publications (1)

Publication Number Publication Date
ES423959A1 true ES423959A1 (en) 1976-05-16

Family

ID=23324918

Family Applications (1)

Application Number Title Priority Date Filing Date
ES423959A Expired ES423959A1 (en) 1973-03-06 1974-03-06 Oral compositions for plaque caries and calculus retardation with reduced staining tendencies

Country Status (13)

Country Link
JP (1) JPS5029758A (en)
AT (1) AT341103B (en)
BE (1) BE811878A (en)
CA (1) CA1028623A (en)
CH (1) CH595101A5 (en)
DE (1) DE2410132A1 (en)
DK (1) DK138579B (en)
ES (1) ES423959A1 (en)
FR (1) FR2220263B1 (en)
GB (1) GB1449302A (en)
IE (1) IE38951B1 (en)
NL (1) NL7402933A (en)
PH (1) PH10396A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8342975A (en) * 1974-08-09 1977-02-03 Procter & Gamble Oral compositions for plaque, caries and calculus retardationwith reduced staining tendencies
US6190642B1 (en) 1988-02-19 2001-02-20 Dentsply Research & Development Corp. Irrigating and lavage compositions
US4961923A (en) * 1988-02-19 1990-10-09 Dentsply Management Corp. Irrigants for use in scaling and/or lavage apparatus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE374658B (en) * 1972-07-31 1975-03-17 Hesselgren S G

Also Published As

Publication number Publication date
GB1449302A (en) 1976-09-15
CA1028623A (en) 1978-03-28
ATA179974A (en) 1977-05-15
DE2410132A1 (en) 1974-09-12
AU6634974A (en) 1975-09-11
IE38951L (en) 1974-09-06
AT341103B (en) 1978-01-25
PH10396A (en) 1977-03-04
FR2220263B1 (en) 1977-11-04
IE38951B1 (en) 1978-07-05
CH595101A5 (en) 1978-01-31
DK138579B (en) 1978-10-02
FR2220263A1 (en) 1974-10-04
NL7402933A (en) 1974-09-10
JPS5029758A (en) 1975-03-25
BE811878A (en) 1974-09-05
DK138579C (en) 1979-03-12

Similar Documents

Publication Publication Date Title
JPS55127384A (en) Novel chromone compound*its manufacture and drug composition containing it
ES8601146A1 (en) Azole derivatives process for their production compositions containing them and their use
PT82386A (en) Process for preparing dichloraniline derivatives
GB1445503A (en) Acylamino acid amides
ES429221A1 (en) N-(1-({107 -phenyl-alkyl)-piperidyl-4)-N-({60 -pyridyl)-carboxylic acid amides and salts thereof
ES416478A1 (en) Oral compositions for plaque caries and calculus retardation with reduced staining tendencies
RU94039539A (en) N,n'-substituted imidocarboxyimide diamides synthesized from hydroxylamines and exhibiting antimicrobial and antiparasitic activity, prophylactic composition, compositions for infection level decrease
IE43139L (en) Bis-biguanide compounds
ES423959A1 (en) Oral compositions for plaque caries and calculus retardation with reduced staining tendencies
GB1507846A (en) Oral compositions for plaque caries and calculus retardation with reduced staining tendencies
ES478622A1 (en) Phenoxyalkyl amines, pharmaceutical compositions containing them, and process for their preparation.
ES8404311A1 (en) Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application.
ES387834A1 (en) Acid amides
ES466887A2 (en) A procedure for the preparation of a substitute phenylamidine. (Machine-translation by Google Translate, not legally binding)
ES483253A1 (en) Cyclic diamides, a process for their preparation and their pharmaceutical compositions.
ES440713A1 (en) Anthelmintically active basically substituted 2-carbalkoxy-amino-benzimidazolyl-5(6)-phenyl ethers and -ketones
ES466867A1 (en) 2,4 - dichlorophenyl - imidazolyl - ethan - ones and -ols a process for their preparation and their use as medicaments
ES423745A1 (en) Procedure for preparing 2-aminoindane derivatives. (Machine-translation by Google Translate, not legally binding)
ES423746A1 (en) Procedure for preparing 2-aminoindane derivatives. (Machine-translation by Google Translate, not legally binding)
ES484525A1 (en) Basic phenyl ethers, pharmaceutical compositions containing them and the preparation of these ethers and compositions.
ES449161A1 (en) Terpnyl phen (oxy)elkyl amideines and their use in pharmaceutical compositions
ES421228A1 (en) Procedure for the obtaining of pirazolic derivatives. (Machine-translation by Google Translate, not legally binding)
ES435422A1 (en) Fungicidal compositions containing disubstituted phosphonates
ES443559A1 (en) Derivatives of n-phenyl-n-aroylalanine and herbicidal compositions containing them
ES8605467A1 (en) 1-(Amino-phenyl)-2-amino-ethanon derivatives, process for their preparation and their use in therapy.